Počet záznamov: 1
Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway
SYS 0169350 LBL 00000naa--2200000-a-4500 005 20250607172525.7 008 201124s2020----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 10
$a Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway / $c X. X. Jiao ... [et al.] 300 $b ilustr., aj fareb., grafy, obr. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d001943 $a nádory prsníka $2 mesh 650 22
$7 sllk_us_auth*d047495 $a PPAR gama $x agonisty $2 mesh 650 22
$7 sllk_us_auth*d000077205 $a pioglitazón $2 mesh 650 22
$7 sllk_us_auth*d045744 $a línia bunková nádorová $2 mesh 650 22
$7 sllk_us_auth*d008807 $a myši inbredné BALB C $2 mesh 653 2-
$a štúdia experimentálna 700 1-
$7 sllk_us_auth*0052748 $a Jiao, X. X. $4 aut 773 0-
$7 nnas $w sllk_us_cat*0168806 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2020 $g Vol. 67, no. 4 (2020), s. 834-842
Počet záznamov: 1